About this paper
Pharma firms have resisted technology-driven predictive marketing mix analysis even though those systems are being used successfully by their peers in other industries. But why? SAS and Pharmaceutical Executive commissioned Strategic Market Research to conduct confidential telephone depth interviews with senior pharma marketing executives to find out why there is a gap between the perceived need for marketing mix predictive analytics and use of the latest technology available to do that kind of analysis.
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions, SAS helps customers at more than 75,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world THE POWER TO KNOW®.